Riskpilot← Back to searchSign inGet full accessPrismakliniken AB
ABActiveOrg 5591149090Storgatan 31Dental practice care activities · NACE 8623Est. 20176 employees
Revenue 2025
SEK 6,3M
-6% vs 2024
EBITDA margin
5.4%
-44% vs 2024
Equity ratio
16.8%
Financial strength
Net profit 2025
SEK 89K
-71% vs 2024
| Revenue | SEK 6,3M | -6% |
| EBITDA | SEK 340K | -44% |
| Net profit | SEK 89K | -71% |
| Total assets | SEK 1,5M | -5% |
| Equity | SEK 247K | -73% |
| Employees | 6 | — |
Legal name
Prismakliniken AB
Org number
5591149090
Legal form
Aktiebolag
NACE code
8623 · Dental practice care activities
Founded
9 juni 2017
Share capital
SEK 50 000
Employees
6 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall bedriva tandvård, utveckling samt försäljning av tandvårdsprodukter.
Address
Storgatan 31
Email
marina.lemke@prismakliniken.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 5 148 | 5 445 | 6 468 | 6 654 | 6 280 |
| Staff expenses | — | — | — | — | −4 038 |
| EBITDA | 232 | 860 | 912 | 604 | 340 |
| Depreciation & amort. | −474 | −361 | −159 | −206 | −217 |
| EBIT | −242 | 499 | 753 | 398 | 123 |
| Net financials | −68 | −54 | −37 | −8 | −3 |
| Profit before tax | −311 | 445 | 716 | 390 | 120 |
| Tax | −0 | −36 | −154 | −87 | −31 |
| Net profit | −311 | 409 | 562 | 303 | 89 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 658 | 1 728 | 1 976 | 1 557 | 1 474 |
| Equity | 153 | 562 | 1 124 | 928 | 247 |
| Long-term debt | 582 | 320 | 0 | 0 | — |
| Short-term debt | 923 | 846 | 852 | 630 | 1 227 |
| Total debt | 1 505 | 1 166 | 852 | 630 | 1 227 |
EBITDA margin
5.4%
This company
15.8%
Market median
-66% vs market
20212025
Equity ratio
16.8%
This company
38.2%
Market median
-56% vs market
20212025
Return on equity
36.1%
This company
18.4%
Market median
+96% vs market
20212025
Net profit margin
1.4%
This company
8.1%
Market median
-83% vs market
20212025
Asset turnover
4.26×
This company
1.12×
Market median
+280% vs market
20212025
Debt / equity
4.97×
This company
0.62×
Market median
-702% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Audit | 2022 | |
AM Chief Executive Officer | Chief Executive Officer | 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
AM Lemke AB
Prismakliniken AB Board members of Prismakliniken AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Alf Jörgen Rickard Sivertsson | Audit | 0 companies |
| Anna Marina Alwine Lemke | Chief Executive Officer | 0 companies |
| Sven Anders Severinsson | Deputy Board Member | 0 companies |